RWE AG Rating Reiterated by AlphaValue (RWE)

RWE AG (FRA: RWE)‘s stock had its “buy” rating reaffirmed by investment analysts at AlphaValue in a note issued to investors on Thursday, StockRatingsNetwork reports. They currently have a €35.00 ($45.45) price target on the stock.

RWE AG (FRA: RWE) traded up 0.41% on Thursday, hitting €26.254. RWE AG has a 52-week low of €25.77 and a 52-week high of €36.302. The stock’s 50-day moving average is currently €35.30.

A number of other analysts have also recently weighed in on RWE. Analysts at RBC Capital reiterated an “upgras de ector perform” rating on shares of RWE AG in a research note to investors on Wednesday. They now have a €28.00 ($36.36) price target on the stock. Separately, analysts at Kepler Cheuvreux reiterated a “reduce” rating on shares of RWE AG in a research note to investors on Wednesday, May 29th.

Six research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. RWE AG currently has an average rating of “Hold” and an average price target of €30.50 ($39.61).

RWE AG is a Germany-based electricity and gas company. It diversifies its activities into seven divisions: Germany, which consists of the Power Generation and Sales and Distribution Networks business area; Netherlands/Belgium; Great Britain; The Central Eastern and South Eastern Europe; Renewables; Upstream Gas and Oil, and Trading/Gas Midstream.

Latest News

iShares Dow Jones U.S. ETF  Announces Quarterly Dividend of $0.68
iShares Dow Jones U.S. ETF Announces Quarterly Dividend of $0.68
Anoncoin 1-Day Volume Reaches $3,149.00
Anoncoin 1-Day Volume Reaches $3,149.00
Pirate Blocks Hits 24 Hour Volume of $0.00
Pirate Blocks Hits 24 Hour Volume of $0.00
Imax  vs. IKONICS  Financial Survey
Imax vs. IKONICS Financial Survey
Deutsche Telekom AG  Given Consensus Recommendation of “Buy” by Brokerages
Deutsche Telekom AG Given Consensus Recommendation of “Buy” by Brokerages
Brokerages Expect Myriad Genetics, Inc.  to Announce $0.37 Earnings Per Share
Brokerages Expect Myriad Genetics, Inc. to Announce $0.37 Earnings Per Share


© 2006-2018 Ticker Report